Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT

Bone Marrow Transplantation

Volumn 20, Issue 8, 1997, Pages 663-668

  Parkkali, T ^a   Stenvik, M ^b   Ruutu, T ^a   Hovi, T ^b   Volin, L ^a   Ruutu, P ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

BMT recipients; Inactivated poliovirus vaccine

Indexed keywords

ANTIBODY; INACTIVATED VACCINE; POLIO NOVUM; POLIOMYELITIS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; POLIOMYELITIS VIRUS 1; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; SUBCUTANEOUS DRUG ADMINISTRATION; VACCINATION;

EID: 0030681017     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700959     Document Type: Article

References (22)

1. Lum LG. Immune recovery after bone marrow transplantation. Hematol Oncol Clin North Am 1990; 4: 659-675.
2. Storek J, Saxon A. Reconstitution of B cell immunity following bone marrow transplantation. Bone Marrow Transplant 1992; 9: 395-408.
3. Engelhard D, Handsher R, Naparstek E et al. Immune response to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295-300.
4. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89-93.
5. Li Volti S, Mauro L, Di Gregorio F et al. Immune status and immune response to diphtheria-tetanus and polio vaccines in allogeneic bone marrow-transplanted thalassemic patients. Bone Marrow Transplant 1994; 14: 225-227.
6. Parkkali T, Ruutu T, Stenvik M et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383-388.
7. Hovi T, Cantell K, Huovilainen A et al. Outbreak of paralytic poliomyelitis in Finland: widespread circulation of antigenically altered poliovirus type 3 in a vaccinated population. Lancet 1986; 2: 1427-1432.
8. Slater PE, Orenstein WA, Morag A et al. Poliomyelitis outbreak in Israel in 1988: a report with two commentaries. Lancet 1990; 335: 1192-1198.
9. Ljungman P, Cordonnier C, de Bock R et al. Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1995; 15: 455-460.
10. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
11. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
12. Albrecht P, van Steenis G, van Wezel AL, Salk J. Standardization of poliovirus neutralizing antibody tests. Rev Infect Dis 1984; 6 (S2): 540-544.
13. Mackall CL, Fleisher TA, Brown MR et al. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. New Engl J Med 1995; 332: 143-149.
14. Annett G, Weinberg K, Kashyap A et al. Post-transplantation thymic function predicts immunocompetence. Blood 1994; 84 (Suppl. 1): 250a (Abstr. 985).
15. Pauksen K, Hammarström V, Ljungman P et al. Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. Clin Infect Dis 1994; 18: 547-552.
16. Parkkali T, Ölander R-M, Ruutu T et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 19: 933-938.
17. Ljungman P, Fridell E, Lönnqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610-615.
18. Ljungman P, Wiklund-Hammarsten M, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496-500.
19. Guinan EC, Molrine DC, Antin JH et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677-684.
20. Saxon A, Mitsuyasu R, Stevens R et al. Designed transfer of specific immune responses with bone marrow transplantation. J Clin Invest 1986; 78: 959-967.
21. Wimperis JZ, Brenner MK, Prentice HG et al. B cell development and regulation after T cell-depleted marrow transplantation. J Immunol 1987; 138: 2445-2450.
22. Molrine DC, Guinan EC, Antin JH et al. Donor immunization with Haemophilus influenzae type b (HIB)-conjugate vaccine in allogeneic bone marrow tranplantation. Blood 1996; 87: 3012-3018.